147 related articles for article (PubMed ID: 36728824)
1. In vitro Activity of Ceftaroline Against an International Collection of Kingella kingae Isolates Recovered From Carriers and Invasive Infections.
Maher JM; Mendes RE; Huynh HK; Porsch EA; St Geme Iii JW; Yagupsky P; Bradley J
Pediatr Infect Dis J; 2023 Mar; 42(3):206-211. PubMed ID: 36728824
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial susceptibility testing of Kingella kingae with broth microdilution and disk diffusion using EUCAST recommended media.
Matuschek E; Åhman J; Kahlmeter G; Yagupsky P
Clin Microbiol Infect; 2018 Apr; 24(4):396-401. PubMed ID: 28760709
[TBL] [Abstract][Full Text] [Related]
3. Activity of ceftaroline-avibactam tested against Gram-negative organism populations, including strains expressing one or more β-lactamases and methicillin-resistant Staphylococcus aureus carrying various staphylococcal cassette chromosome mec types.
Castanheira M; Sader HS; Farrell DJ; Mendes RE; Jones RN
Antimicrob Agents Chemother; 2012 Sep; 56(9):4779-85. PubMed ID: 22733066
[TBL] [Abstract][Full Text] [Related]
4. Comparative ceftaroline activity tested against pathogens associated with community-acquired pneumonia: results from an international surveillance study.
Jones RN; Farrell DJ; Mendes RE; Sader HS
J Antimicrob Chemother; 2011 Apr; 66 Suppl 3():iii69-80. PubMed ID: 21482572
[TBL] [Abstract][Full Text] [Related]
5. Beta-lactamase production by Kingella kingae in Israel is clonal and common in carriage organisms but rare among invasive strains.
Yagupsky P; Slonim A; Amit U; Porat N; Dagan R
Eur J Clin Microbiol Infect Dis; 2013 Aug; 32(8):1049-53. PubMed ID: 23479041
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of ceftaroline against multidrug-resistant Staphylococcus aureus and Streptococcus pneumoniae: a review of published studies and the AWARE Surveillance Program (2008-2010).
Farrell DJ; Castanheira M; Mendes RE; Sader HS; Jones RN
Clin Infect Dis; 2012 Sep; 55 Suppl 3():S206-14. PubMed ID: 22903953
[TBL] [Abstract][Full Text] [Related]
7. Activity analyses of staphylococcal isolates from pediatric, adult, and elderly patients: AWARE Ceftaroline Surveillance Program.
Sader HS; Flamm RK; Farrell DJ; Jones RN
Clin Infect Dis; 2012 Sep; 55 Suppl 3():S181-6. PubMed ID: 22903950
[TBL] [Abstract][Full Text] [Related]
8. Ceftaroline activity tested against bacterial isolates from pediatric patients: results from the assessing worldwide antimicrobial resistance and evaluation program for the United States (2011-2012).
Sader HS; Mendes RE; Farrell DJ; Flamm RK; Jones RN
Pediatr Infect Dis J; 2014 Aug; 33(8):837-42. PubMed ID: 25222304
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of novel anti-MRSA cephalosporins and comparator antimicrobial agents against staphylococci involved in prosthetic joint infections.
Isnard C; Dhalluin A; Malandain D; Bruey Q; Auzou M; Michon J; Giard JC; Guérin F; Cattoir V
J Glob Antimicrob Resist; 2018 Jun; 13():221-225. PubMed ID: 29421316
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of ceftaroline against gram-positive and gram-negative pathogens isolated from patients in Canadian hospitals in 2009.
Karlowsky JA; Adam HJ; Decorby MR; Lagacé-Wiens PR; Hoban DJ; Zhanel GG
Antimicrob Agents Chemother; 2011 Jun; 55(6):2837-46. PubMed ID: 21402844
[TBL] [Abstract][Full Text] [Related]
11. In vitro susceptibility of ceftaroline against clinically important Gram-positive cocci, Haemophilus species and Klebsiella pneumoniae in Taiwan: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) in 2012-2018.
Jean SS; Lee WS; Ko WC; Hsueh PR
J Microbiol Immunol Infect; 2021 Aug; 54(4):627-631. PubMed ID: 32451293
[TBL] [Abstract][Full Text] [Related]
12. Invasive Kingella kingae infections in children: clinical and laboratory characteristics.
Dubnov-Raz G; Scheuerman O; Chodick G; Finkelstein Y; Samra Z; Garty BZ
Pediatrics; 2008 Dec; 122(6):1305-9. PubMed ID: 19047250
[TBL] [Abstract][Full Text] [Related]
13. AWARE Ceftaroline Surveillance Program (2008-2010): trends in resistance patterns among Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States.
Pfaller MA; Farrell DJ; Sader HS; Jones RN
Clin Infect Dis; 2012 Sep; 55 Suppl 3():S187-93. PubMed ID: 22903951
[TBL] [Abstract][Full Text] [Related]
14. Spectrum and potency of ceftaroline tested against leading pathogens causing community-acquired respiratory tract infections in Europe (2010).
Farrell DJ; Flamm RK; Jones RN; Sader HS
Diagn Microbiol Infect Dis; 2013 Jan; 75(1):86-8. PubMed ID: 23146404
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of ceftaroline-avibactam against gram-negative and gram-positive pathogens isolated from patients in Canadian hospitals from 2010 to 2012: results from the CANWARD surveillance study.
Karlowsky JA; Adam HJ; Baxter MR; Lagacé-Wiens PR; Walkty AJ; Hoban DJ; Zhanel GG
Antimicrob Agents Chemother; 2013 Nov; 57(11):5600-11. PubMed ID: 23979759
[TBL] [Abstract][Full Text] [Related]
16. Whole-Genome Sequencing Reveals Differences among Kingella kingae Strains from Carriers and Patients with Invasive Infections.
Murik O; Zeevi DA; Mann T; Kashat L; Assous MV; Megged O; Yagupsky P
Microbiol Spectr; 2023 Jun; 11(3):e0389522. PubMed ID: 37195188
[TBL] [Abstract][Full Text] [Related]
17. Spectrum and potency of ceftaroline tested against leading pathogens causing skin and soft-tissue infections in Europe (2010).
Farrell DJ; Flamm RK; Sader HS; Jones RN
Int J Antimicrob Agents; 2013 Apr; 41(4):337-42. PubMed ID: 23466338
[TBL] [Abstract][Full Text] [Related]
18. Ceftaroline activity against Staphylococcus aureus isolated from patients with infective endocarditis, worldwide (2010-2019).
Sader HS; Carvalhaes CG; Mendes RE
Int J Infect Dis; 2021 Jan; 102():524-528. PubMed ID: 33207274
[TBL] [Abstract][Full Text] [Related]
19. Ceftaroline activity against organisms isolated from respiratory tract infections in USA hospitals: results from the AWARE Program, 2009-2011.
Flamm RK; Sader HS; Jones RN
Diagn Microbiol Infect Dis; 2014 Apr; 78(4):437-42. PubMed ID: 24582578
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of ceftaroline and comparator antimicrobials against European and Middle East isolates from complicated skin and skin-structure infections collected in 2008-2009.
Morrissey I; Leakey A; Northwood JB
Int J Antimicrob Agents; 2012 Sep; 40(3):227-34. PubMed ID: 22796201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
